|
Volumn 54, Issue 11, 2000, Pages 494-498
|
Pharmacokinetics of cyclophosphamid, adriamycin and adramycin-prodrug (HMR 1826) using the ex-vivo isolated perfused human lungmodel (IHLP);Pharmakokinetik von cyclophosphamid, adriamycin und adramycin-prodrug (HMR 1826) im ex-vivo-isolierten perfundierten humanen lungenresektionsmodell (IHLP)
a e c b a d d c e b |
Author keywords
Anticancer drugs; Isolated lung perfusion; Lung cancer
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
N (4 BETA GLUCURONYL 3 NITROBENZYLOXYCARBONYL)DOXORUBICIN;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER STAGING;
CONTROLLED STUDY;
DRUG TISSUE LEVEL;
FIRST PASS EFFECT;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LUNG CARCINOMA;
LUNG MODEL;
LUNG PERFUSION;
LUNG SURGERY;
LYMPH NODE;
PRIORITY JOURNAL;
TISSUE PERFUSION;
ANTINEOPLASTIC AGENTS;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
GLUCURONATES;
HUMANS;
LUNG;
LUNG NEOPLASMS;
LYMPH NODES;
PERFUSION;
PRODRUGS;
|
EID: 0033663484
PISSN: 09348387
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2000-8250 Document Type: Article |
Times cited : (5)
|
References (18)
|